During the past decade, Clinical Trials, Inc. conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 24 clinical trials were completed, i.e. on average, 160% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 13 clinical trials were completed. i.e. 433.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Trials, Inc." #1 sponsor was "Eisai Inc." with 6 trials, followed by "Pfizer" with 5 trials sponsored, "Impax Laboratories, LLC" with 4 trials sponsored, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored and "SK Life Science, Inc." with 3 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Trials, Inc." #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Bausch Health Americas, Inc." with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator and "Ligand Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Trials, Inc." are "Parkinson's Disease" (7 trials), "Alzheimer's Disease" (6 trials), "Epilepsy" (6 trials), "Parkinson Disease" (4 trials) and "Alzheimer Disease" (3 trials). Many other conditions were trialed in "Clinical Trials, Inc." in a lesser frequency.

Most popular intervention types in "Clinical Trials, Inc." are "Drug" (43 trials), "Other" (4 trials), "Biological" (3 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "placebo" (6 trials), "Bapineuzumab 0.5 mg/kg" (3 trials), "APL-130277" (2 trials) and "Bapineuzumab 1.0 m/kg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Trials, Inc." are 47 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Trials, Inc.". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in Clinical Trials, Inc., undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Trials, Inc., 0 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Clinical Trials, Inc. has several departments that took part in Clinical trials: "Clinical Trials, Inc. and Arkansas Epilepsy Program" - 2 trials